期刊文献+

移植心肌样细胞对心肌梗死后功能性室壁瘤大鼠心功能的影响

Effect of cardiomyocytes-like cells transplantation on cardiac function of rats with ventricular aneurysm after myocardial infarction
下载PDF
导出
摘要 目的探讨心肌内注射心肌样细胞对心肌梗死(MI)后功能性室壁瘤大鼠心功能的影响。方法结扎大鼠冠状动脉前降支形成MI,4周后,用超声心动图检测并筛选形成功能性室壁瘤者,并随机分为两组,即移植组(n=10),在室壁瘤部位及周边点状注射5-氮杂胞苷(5-Aza)诱导骨髓间充质干细胞(MSCs)分化、并用4,6-二脒基-2-苯基吲哚(DAPI)标记的心肌样细胞(10^6-10^7个);对照组(n=10):注射生理盐水。另取10只健康大鼠作为假手术组,只开胸不做任何处理。4周后,用超声心动图和血流动力学方法测定功能性室壁瘤大鼠的心功能,在荧光显微镜下观察DAPI标记的移植细胞的存活情况。结果超声心动图的结果显示,对照组和移植组的左室舒张末内径(LVEDD)和左室收缩末内径(LVESD)均较假手术组增高(P〈0.01),而移植组较对照组有所降低[(8.749±0.091)、(5.109±0.171)VS(9.219±0.059)mm、(5.942±0.092)mm,P〈0.05];对照组和移植组的短轴缩短率(△Fs)及左室射血分数(LVEF)均较假手术组明显降低(P〈0.01),移植组较对照组两者有所增高[(32.70±1.283)、(45.78±1.796)VS(22.80±0.593)%、(31.92±0.830)%,P〈0.05]。血流动力学检测结果显示,移植组、对照组和假手术组的左室舒缩压差(LVDP)和左室正负最大变化速率(±dp/dtmax),分别为(152.9±0.669)、(4109±33.86)、(-3579±49.09),(122.5±2.639)、(3823±73.50)、(-2828±60.96)和(183.6±2.348)mmHg、(6695±80.17)mmHg/s、(-6294±71.39)mmHg/s,假手术组优于对照组和移植组(P〈0.01),移植组优于对照组(P〈0.05)。在荧光显微镜下可以观察到移植组的心肌组织中有存活的标记细胞。结论移植心肌样细胞能显著改善MI后功能性室壁瘤大鼠的心功能,为治疗功能性室壁瘤提供-种新的治疗思路和为临床研究奠定基础。 AIM To observe the effect of cardiomyocytes-like cells induced from mesenchymal stem cells (MSCs) transplantation on the cardiac function of rats with functional ventricular aneurysm after myocardial infarction. METHODS Isolated MSCs from rats bone marrow were cultured in cell culture medium with 5-azacytidine (5-Aza) and labeled with 4,6-diamidino-2-phenylindole (DAPI). Functional ventricular aneurysm model of rat was established by ligating the left enterior descending coronary artery and selected by ultrasonic cardiography (UCG) after 4 weeks. The rats with functional ventrieular aneurysm were divided into eardiomyocytes-like cells group and control group then cardiomyoeytes-like ceils (10^6- 10^7) or sodium chloride were injected at several different points into the broad area of ventrieular aneurysm. In addition, 10 SD rats served as sham operation group ( thoracotomy twice without ligation of coronary artery. Four weeks after transplantation, the cardiac function of the rats was measured by UCG and multichannel physiological recorder and the transplanted cardiomyocytes-like cells were detected by fluorescent micro- scope. RESULTS UCG showed that left ventricular end diastolic dimension (LVEDD) and left ventric- ular end systolic (LVESD) dimension in the three groups were (8. 749 ±0. 091 ), (5. 109 ±0. 171 ); (9.219±0.059), (5.942 ±0.092) and (6.344 ±0.296) ram, (3. 116 ±0.275) ram, with sham operation group best ( P 〈 0.01 ) and cardiomyocytes-like cells group better than control group ( P 〈 0. 05). Fractional shortening (GFS) and left ventrieular ejection fraction (LVEF) in the three groups were (32.70 ±1.283), (45.78 ±- 1.796); (22.80 ±0.593), (31.92 ±0.830) and (54.90 ± 2. 742) %, (74. 12 ± 2. 760) %, with sham operation group highest ( P 〈 0.01 ) and cardiomyocytes-like cells group higher than control group ( P 〈 0.05 ). Muhichannel physiological recorder showed that left ventricular developed pressure (LVDP) and ( ± dp/dtmax ) in the three groups were ( 152. 9 ±_ 0. 669 ), (4 109±_33.86), (-3579±49.09); (122.5±2.639), (3 823 ±73.50), ( -2 828 ±_60.96) and (183.6 ±2. 348) mmHg, (6 695 ±80. 17) mmHg/s, ( -6 294 ±71.39) mmHg/s, with sham opera- tion group best(P 〈 0.01 ) and cardiomyocytes-like cells group better than control group ( P 〈 0. 05 ). Labeled cardiomyocytes-like cells were found on the broad area of ventricular aneurysm in cardiomyo- cytes-like cells group. CONCLUSION Cardiomyocytes-like cells transplantation can improve the heart function of rat with functional ventricular aneurysm after myocardial infarction, provide a new therapeutic way and lay fundation for clinical reaserch.
出处 《心脏杂志》 CAS 2009年第2期197-200,共4页 Chinese Heart Journal
关键词 骨髓间充质干细胞 心肌样细胞 移植 功能性室壁瘤 mesenchymal stem cells cardiomyocytes-like cells transplantation functional ventricular aneurysm
  • 相关文献

参考文献8

  • 1Berry MF, Engler AJ, Woo YJ, et al. Mesenchymal stem cell injection after myocardial infarction improves myocardial compliance[ J ]. Am J Physiol Heart Circ Physiol, 2006, 290 (6) :H2196 - H2203.
  • 2Behrami AP, Urbanek K, Ksjstura J, et al. Evidence that human cardiac myocytes divide after myocardial infarction [ J ]. N Engl J Med, 2001, 344(23 ) :1750 - 1757.
  • 3Behrami AP, Barlucchi L, Torella D, et al. Aduh cardiac stem cells are multipotent and support myocardial regeneration [ J ]. Cell, 2003, 114(6) :763 -776.
  • 4Behfar A, Terzic A. Derivation of a cardiopoietic population from human mesenchymal stem cells yiehts cardiac progeny [ J ]. Nat Clin Pract Cardiovasc Med, 2006, 3 ( Suppl 1 ) : S78 - S82.
  • 5钱海燕,杨跃进.干细胞移植心肌再生监测的示踪技术研究进展[J].中华医学杂志,2005,85(40):2873-2876. 被引量:5
  • 6Nygren JM, Jovinge S, Breitbach M, et al. Bone marrow-derived hematopoietic cells generate cardiocytes at a low frequency through cell fusion, but not transdifferentiation [ J ]. Nat Med, 2004, 10 (5) : 494 - 501.
  • 7Tomita S, Mickle DA, Weisel RD, et al. Improved hearl function with myogenesis and angiogenesis aler autologous porcine bone marrow stromal cell transplation [ J ]. J Thorac Cardiovase Surg, 2002, 123(6) :1132 - 1140.
  • 8Fukuda K. Development of regeneration cardiomyocytes from mesenchymal stem cells for cardiovascular tissue engineering[ J ]. Artif Organs, 2001, 25(3) :187 - 193.

二级参考文献28

  • 1Heim R, Prasher DC, Tsieh RY, et al.Wave length mutation and postranslational autoxidation of green fluorescent protein. PNAS,1994,91:12501-12504.
  • 2Ormo M, Cubitt AB, Kallio K, et al. Crystal structure of the Aequorea Victoria green fluorescent protein.Science,1996,73:1392-1395.
  • 3Orlic D, Kajstura J, Chimenti S,et al. Bone marrow cells regenerate infarcted myocardium. Nature,2001, 410:701-705.
  • 4Min JY, Sullivan MF, Yang Y, et al. Significant improvement of heart function by cotransplantation of human mesenchymal stem cells and fetal cardiomyocytes in postinfarcted pigs. Ann Thorac Surg,2002,74:1568-1575.
  • 5Kuramochi Y, Fukazawa R, Migita M, et al. Cardiomyocyte regeneration from circulating bone marrow cells in mice. Pediatr Res,2003,54:319-325.
  • 6Nygren JM, Jovinge S, Breitbach M, et al. Bone marrow-derived hematopoietic cells generate cardiomyocytes at a low frequency through cell fusion, but not transdifferentiation.Nat Med,2004,10:494-501.
  • 7Toma C, Pittenger MF, Cahill KS, et al. Human mesenchymal stem cells differentiate to a cardiomyocyte phenotype in the adult murine heart. Circulation,2002,105:93-98.
  • 8Saito T, Kuang JQ, Lin CC,et al. Transcoronary implantation of bone marrow stromal cells ameliorates cardiac function after myocardial infarction. J Thorac Cardiovasc Surg, 2003,126:114-123.
  • 9Mangi AA, Noiseux N, Kong D, et al. Mesenchymal stem cells modified with Akt prevent remodeling and restore performance of infarcted hearts. Nat Med,2003,9:1195-1201.
  • 10Liu J, Hu Q, Wang Z, et al. Autologous stem cell transplantation for myocardial repair. Am J Physiol Heart Circ Physiol,2004,287:H501- H511.

共引文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部